CCNYL3

Chr 16

cyclin Y like 3 (pseudogene)

Predicted to be involved in regulation of canonical Wnt signaling pathway. Predicted to be active in plasma membrane. [provided by Alliance of Genome Resources, Jul 2025]

0
Active trials
6
Pathogenic / LP
14
ClinVar variants
0
Pubs (1 yr)
Missense Z
LOEUF
Clinical SummaryCCNYL3
📋
ClinVar Variants
6 Pathogenic / Likely Pathogenic· 3 VUS of 14 total submissions
Some data sources returned errors (1)

pubtator: Error: PubTator3 HTTP 502

Population Genetics & Constraint

Constraint data not available from gnomAD.

DN
0.6743th %ile
GOF
0.5562th %ile
LOF
0.3455th %ile

The highest-scoring mechanism for this gene is dominant-negative.

DNprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

14 submitted variants in ClinVar

Classification Summary

Pathogenic5
Likely Pathogenic1
VUS3
Likely Benign5
5
Pathogenic
1
Likely Pathogenic
3
VUS
5
Likely Benign

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories· variant type breakdown unavailable

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
5
Likely Pathogenic
1
VUS
3
Likely Benign
5
Benign
0
Total14

Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

CCNYL3 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Landmark / reviewRecent case evidence

No publications found for CCNYL3